WHO wants to review Russian vaccine safety data

Agence France-Presse

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/life/08/11/20200811-medics-don-protective-suits-tnyt.jpg"/><figcaption>Medics don protective suits before entering the &quot;red zone&quot; of the Kommunarka hospital in Moscow, May 14, 2020. A botched government effort to reward people keeping the coronavirus in check has left doctors and nurses who demand their due facing scrutiny. Sergey Ponomarev, The New York Times/File</figcaption></figure></div>GENEVA - The World Health Organization said any WHO stamp of approval on a COVID-19 vaccine candidate would require a rigorous safety data review, after Russia announced Tuesday it had approved a vaccine.President Vladimir Putin said Russia had become the first country to approve a vaccine offering &quot;sustainable immunity&quot; against the new coronavirus.&quot;We are in close contact with the Russian health authorities and discussions are ongoing with respect to possible WHO pre-qualification of the vaccine,&quot; the United Nations health agency&#x27;s spokesman Tarik Jasarevic told reporters in Geneva at an online press briefing.&quot;Pre-qualification of any vaccine includes the rigorous review and assessment of all the required safety and efficacy data.&quot;Russia&#x27;s Sputnik V vaccine has been developed by the Gamaleya research institute in coordination with the country&#x27;s defense ministry.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/08/11/20/russia-has-developed-first-coronavirus-vaccine-putin">Russia has developed &#x27;first&#x27; coronavirus vaccine: Putin</a></li></ul>A total of 165 candidate vaccines are being worked on around the world, according to the latest WHO overview produced on July 31.Of those, 139 are still in pre-clinical evaluation, while the other 26 are in the various phases of being tested on humans, of which 6 are the furthest ahead, having reached Phase 3 of clinical evaluation.The Gamaleya candidate being produced in Russia, which is among the 26 being tested on humans, is listed as being in Phase 1.Kirill Dmitriev, the head of the Russian Direct Investment Fund that finances the vaccine project, said Phase 3 trials would start on Wednesday, industrial production was expected from September and that 20 countries had pre-ordered more than a billion doses.<div>&#x27;STAMP OF QUALITY&#x27;</div>&quot;Every country has national regulatory agencies that approve the use of vaccines or medicines on its territory,&quot; Jasarevic explained.&quot;WHO has in place a process of pre-qualification for vaccines but also for medicines. Manufacturers ask to have the WHO pre-qualification because it is a sort of stamp of quality.&quot;To get this, there is a review and assessment of all required safety and efficacy data that are gathered through the clinical trials. WHO will do this for any candidate vaccine.&quot;The pandemic has seen an unprecedented mobilization of funding and research to rush through a vaccine that can protect billions of people worldwide.&quot;We are encouraged by the speed by which several candidate vaccines have been developing and as we have been always saying, we hope some of these vaccines will prove to be safe and efficient,&quot; said Jasarevic.&quot;Accelerating progress does not mean compromising on safety,&quot; he said.

The Gamaleya candidate being produced in Russia, which is among the 26 being tested on humans, is listed as being in Phase 1.

The Gamaleya candidate being produced in Russia, which is among the 26 being tested on humans, is listed as being in Phase 1.

WHO wants to review Russian vaccine safety data | ABS-CBN

Halalan 2025

Entertainment

News

Metro.Style

Lifestyle

Sports

More

Traffic

Horoscope

Overseas

WHO wants to review Russian vaccine safety data

WHO wants to review Russian vaccine safety data

Agence France-Presse

Published Aug 11, 2020 08:39 PM PHT

Read More:

ANC

Russia COVID-19 vaccine

Russia COVID-19 cure

Russia COVID-19 treatment

World Health Organization Russia vaccine review

WHO Russia vaccine review

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.